gcHBB-SCD

N/A

Report date: 2025/09/05 14:00:00

Base Information

Drug NamegcHBB-SCD

Drug Alias NamegcHBB-SCD

ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9Cell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionHemoglobin beta chain stimulants

TargetsHemoglobin beta chain

Therapy Area/IndicationsAnemia, Sickle Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesStanford University

China Registration ClassN/A

Develop Information

Active CompaniesStanford University

Inactive CompaniesN/A

Active IndicationsAnemia, Sickle Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A